PTAB challenges

Proceedings overview

There is currently one active AIA trial proceeding on US patent 11825860, IPR2025-01199, which has reached the "Trial Instituted" stage. This means that the PTAB has decided to review the patentability of certain claims, and the trial is ongoing. For a defendant, this creates an uncertain defensive posture, as the patent's claims are actively under review and could potentially be invalidated.

IPR2025-01199 — Arla Foods amba v. Leprino Foods Co

• Type: Inter Partes Review
• Filed: 2025-07-15
• Status: Trial Instituted. The PTAB has decided to proceed with a trial to review the patentability of the challenged claims.
• Judge panel: Information not publicly available yet through web search.
• Petition grounds: Information regarding specific claims challenged, prior art, and statutory bases (§ 102 / § 103 / § 112) is not yet publicly available via web search for the institution decision.
• Institution decision: The PTAB instituted trial on 2026-01-13. The specific reasoning for institution and the claims at issue are not yet publicly available through web search results for the full decision document.
• Final Written Decision (if issued): Not yet issued, as the proceeding status is "Trial Instituted." A Final Written Decision is typically due within one year of institution, absent good cause for extension.
• Settlement / termination: Not applicable at this stage.
• Appeal: Not applicable at this stage, as no Final Written Decision has been issued.
• Defensive value: The institution of this IPR indicates that the PTAB found a reasonable likelihood that at least one challenged claim is unpatentable. This introduces significant uncertainty regarding the validity of the patent, which can be leveraged by a defendant in negotiations or litigation. However, no claims have been definitively canceled yet.

Strategic summary

As of the current date, US patent 11825860 is subject to one active Inter Partes Review, IPR2025-01199, initiated by Arla Foods amba. The PTAB has instituted a trial, meaning it has determined there is a reasonable likelihood of at least one challenged claim being unpatentable. However, specific details about which claims are under review, the prior art cited, and the precise grounds for institution are not publicly available from the current search results. Without a Final Written Decision, no claims have been canceled or sustained, and the patent's validity remains in question.

Given the "Trial Instituted" status, the estoppel landscape under § 315(e)(2) will only become relevant for Arla Foods amba and its privies after a Final Written Decision is issued. At that point, they would be barred from asserting any invalidity grounds that were raised or reasonably could have been raised in the IPR. For other potential defendants not in privity with Arla Foods amba, all prior art grounds remain available for challenge. The presence of a petitioner like Arla Foods amba, a known player in the dairy industry, suggests a direct interest in the patent's validity.

Recommended next steps

• Monitor the IPR2025-01199 proceeding closely. The PTAB typically issues a Final Written Decision within one year of institution, which would be by approximately 2027-01-13. The full institution decision, when publicly available, should be reviewed to understand the specific claims challenged and the PTAB's initial reasoning.
• Once the Institution Decision is available, review the claims under challenge and the prior art asserted. If facing assertion, assess whether your own prior art search yields similar or stronger grounds.
• If a Final Written Decision is issued, immediately review its disposition at a claim-by-claim granularity. Any invalidated claims would significantly impact an ongoing assertion. The decision will be accessible via the USPTO PTAB Decisions portal.
• Consider engaging with Arla Foods amba, if appropriate, to understand the scope of their challenge and potential outcomes, especially if you are facing similar assertions from Leprino Foods Co.## Proceedings overview

There is currently one active AIA trial proceeding on US patent 11825860, IPR2025-01199, which has reached the "Trial Instituted" stage. This means that the Patent Trial and Appeal Board (PTAB) has decided to review the patentability of certain claims, and the trial is ongoing. For a defendant, this creates an uncertain defensive posture, as the patent's claims are actively under review and could potentially be invalidated.

IPR2025-01199 — Arla Foods amba v. Leprino Foods Co

• Type: Inter Partes Review
• Filed: 2025-07-15
• Status: Trial Instituted. The PTAB has decided to proceed with a trial to review the patentability of the challenged claims.
• Judge panel: The specific judge panel information for the institution decision is not publicly available through the performed web searches.
• Petition grounds: Details regarding the specific claims challenged, the prior art cited, and the statutory bases (§ 102 / § 103 / § 112) for the petition are not publicly available through the performed web searches.
• Institution decision: The PTAB instituted trial on 2026-01-13. The specific reasoning for institution, including the particular claims found to have a reasonable likelihood of unpatentability, is not publicly available through the performed web searches. The Director may institute an IPR if there is a "reasonable likelihood that the petitioner would prevail with respect to at least 1 of the claims challenged in the petition."
• Final Written Decision (if issued): Not yet issued, as the proceeding status is "Trial Instituted." A Final Written Decision is typically due within one year of institution, absent good cause for extension.
• Settlement / termination: Not applicable at this stage.
• Appeal: Not applicable at this stage, as no Final Written Decision has been issued.
• Defensive value: The institution of this IPR indicates that the PTAB found a reasonable likelihood that at least one challenged claim is unpatentable, introducing significant uncertainty regarding the patent's validity. This uncertainty can be a valuable point for a defendant in ongoing or potential negotiations. However, no claims have been definitively canceled or sustained, and the trial is ongoing.

Strategic summary

As of the current date, US patent 11825860 is subject to one active Inter Partes Review, IPR2025-01199, initiated by Arla Foods amba against Leprino Foods Co. The PTAB has instituted a trial, meaning it has determined there is a reasonable likelihood that at least one challenged claim is unpatentable. However, the specific details regarding which claims are under review, the prior art cited, and the precise grounds for institution are not publicly available through the conducted web searches. Without a Final Written Decision, no claims have been canceled or sustained, and the patent's validity remains in question.

Given the "Trial Instituted" status, the estoppel landscape under § 315(e)(2) will only become relevant for Arla Foods amba and its privies after a Final Written Decision is issued. At that point, they would be barred from asserting any invalidity grounds that were raised or reasonably could have been raised in the IPR. For other potential defendants not in privity with Arla Foods amba, all prior art grounds remain available for challenge. The presence of a petitioner like Arla Foods amba, a known entity in the food industry, suggests a direct interest in the patent's validity related to their business.

Recommended next steps

• Monitor the IPR2025-01199 proceeding closely. The PTAB typically issues a Final Written Decision within one year of institution, which would be by approximately 2027-01-13 (one year from the institution date of 2026-01-13).
• Once the Institution Decision document becomes publicly available, immediately review its contents to understand the specific claims under challenge, the prior art asserted, and the PTAB's detailed reasoning for institution. This information is crucial for assessing the strength of the challenge and informing any defensive strategies. These decisions are usually found on the USPTO PTAB Decisions portal.
• If a Final Written Decision is ultimately issued, thoroughly review its disposition at a claim-by-claim granularity. Any invalidated claims would significantly impact an ongoing assertion of the patent.
• Consider the implications of this active proceeding if facing assertions from Leprino Foods Co. The uncertainty surrounding the patent's validity due to the ongoing IPR can be a strong point in negotiations.